Suppr超能文献

未患有精神障碍且服用常规剂量普瑞巴林的患者中普瑞巴林撤药:病例系列和文献复习。

Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review.

机构信息

Department of Neuropsychiatry, Japanese Red Cross Akita Hospital, Akita City, Japan.

Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita City, Japan.

出版信息

Neuropsychopharmacol Rep. 2021 Sep;41(3):434-439. doi: 10.1002/npr2.12195. Epub 2021 Aug 12.

Abstract

Pregabalin is a drug that can cause psychiatric symptoms via pregabalin withdrawal. Prior reports on pregabalin withdrawal have mainly focused on cases with pregabalin dependence or abuse, and little attention has been paid to patients who are prescribed regular doses of pregabalin. Herein, we report three cases of pregabalin withdrawal in patients without psychiatric disorders, taking regular doses of pregabalin, who developed psychiatric symptoms such as insomnia and anxiety after abrupt discontinuation of pregabalin. In addition, we conducted a systematic review of six case reports (previous studies) of pregabalin withdrawal under regular doses of pregabalin. Among the six cases, three patients had no comorbid mental or substance use disorders, the dose of pregabalin ranged from 150 to 600 mg/d, and the duration of pregabalin use ranged from a few weeks to many years. Of these six cases of pregabalin withdrawal, five had psychopathological symptoms, three had vegetative symptoms, and three had neurologic and physical complications. We concluded that since pregabalin withdrawal can occur even with regular doses and short-term use, clinicians must carefully reduce pregabalin doses when reducing or discontinuing treatment, paying close attention to withdrawal symptoms. Our case series sheds light on the scant evidence from previous research on physical dependence in patients who are taking regular doses of pregabalin. Furthermore, our cases were also valuable in demonstrating that pregabalin withdrawal can occur even after a relatively short period of 2 months.

摘要

普瑞巴林是一种药物,通过普瑞巴林戒断可引起精神症状。先前关于普瑞巴林戒断的报告主要集中在有普瑞巴林依赖或滥用的病例上,而很少关注接受常规剂量普瑞巴林治疗的患者。在此,我们报告了 3 例无精神障碍的患者在突然停止普瑞巴林治疗后出现失眠和焦虑等精神症状的案例,这些患者服用常规剂量的普瑞巴林。此外,我们对 6 例(以往研究)常规剂量普瑞巴林戒断的病例进行了系统回顾。在这 6 例病例中,有 3 例患者没有共病精神或物质使用障碍,普瑞巴林的剂量为 150-600mg/d,普瑞巴林的使用时间从数周到数年不等。在这 6 例普瑞巴林戒断病例中,有 5 例出现精神病理学症状,3 例出现植物性症状,3 例出现神经系统和身体并发症。我们的结论是,由于即使在常规剂量和短期使用的情况下也可能发生普瑞巴林戒断,因此当减少或停止治疗时,临床医生必须小心减少普瑞巴林的剂量,并密切关注戒断症状。我们的病例系列为之前关于接受常规剂量普瑞巴林治疗的患者身体依赖的研究提供了很少的证据。此外,我们的病例还证明,即使在相对较短的 2 个月后也可能发生普瑞巴林戒断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f0f/8411313/4404ca4d5cf8/NPR2-41-434-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验